FADS1, a lipid metabolism-related diagnostic biomarker in KIRC
FADS1 could serve as a prognostic biomarker associated with immunity in KIRC, highlighting its potential as a diagnostic and therapeutic target. The study underscores the importance of further research into FADS1's role in lipid metabolism and immune infiltration to develop effective therapeutic strategies.
Authors
- Tianmin Yang
- Haiying Yu (ORCID: https://orcid.org/0000-0002-7648-7930)
- Kai Sun (ORCID: https://orcid.org/0000-0001-8866-8838)
- Fan Peng
- Qinghua Xia
- Yuhu Hao
- Qingshun Bai (ORCID: https://orcid.org/0000-0002-8626-4431)
Institutions
- Shandong University (CN)
- Shandong Provincial Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-04-06
- DOI
- https://doi.org/10.1007/s12672-025-02255-2
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province